Xbrane Biopharma to participate at Redeye Biosimilar/Drug Delivery 16 April

Corporate Information




Other Corporate Information

Xbrane Biopharma AB (publ) ("Xbrane" or "the Company”) represented by Martin Åmark, CEO, will tomorrow participate at Redeye’s capital markets day about Biosimilar/Drug Delivery.

On April 16, at 09:55 AM, Martin Åmark, CEO, Xbrane Biopharma, will present the latest events and development in the Company at Redeye. The presentation will be live and can be followed at https://www.redeye.se/events#/event/585887 where the presentation afterwards will be available on Xbrane’s company page at Redeye Universe https://www.redeye.se/company/xbrane-biopharma.